Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)
Clinical trial NCT05798715 · COMPLETED
Trial details
- NCT number
- NCT05798715
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2022-12-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.